New incretin-based medicines will allow weight and diabetes control with a single weekly dose
The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional ...
Oct 28, 2015
0
13